Chairs and Committees

GLOBAL FORUM CHAIRS AND COMMITTEES

Global Forum Co-Chairs

  • Danilo Casimiro, former Chief Scientific Officer, Aeras
  • Nick Drager, TuBerculosis Vaccine Initiative
  • David Lewinsohn, Stop TB Partnership Working Group on New Vaccines
  • Soumya Swaminathan, former Secretary, Department of Health Research and former Director-General, Indian Council of Medical Research

Organizing Committee

  • Nisheeth Agarwal, Translational Health Science and Technology Institute (India)
  • Krishnamohan Atmakuri, Translational Health Science and Technology Institute (India)
  • Sharon Chan, Aeras (China)
  • Ann Ginsberg, Aeras (USA)
  • Willem Hanekom, Bill & Melinda Gates Foundation (USA)
  • Mark Hatherill, South African Tuberculosis Vaccine Initiative, University of Cape Town (South Africa)
  • Blessina Kumar, Global Coalition of TB Activists (India)
  • David Lewinsohn, Stop TB Partnership Working Group on New Vaccines (USA)
  • Jyoti Logani, Department of Biotechnology, Ministry of Science and Technology (India)
  • Manjula Singh, Indian Council of Medical Research (India)
  • Ramandeep Singh, Translational Health Science and Technology Institute (India)
  • Frank Verreck, TuBerculosis Vaccine Initiative (Netherlands)
  • Jennifer Woolley, Global Forum Project Director (USA)

India Advisory Panel

  • R.R. Gangakhedkar, Indian Council of Medical Research
  • Sarala Balachandran, Council of Scientific and Industrial Research
  • K.N. Balaji, Indian Institute of Science
  • T.S. Balganesh, GangaGen Biotechnologies Private Ltd
  • Rohan Dhiman, National Institute of Technology, Rourkela, Odisha
  • Rajesh Gokhale, National Institute of Immunology
  • Randeep Guleria, All India Institute of Medical Science
  • Suresh Jadhav, Serum Institute of India
  • Manjul Joshipura, Cadila Pharmaceuticals
  • Dhiraj Kumar, International Centre for Genetic Engineering and Biotechnology
  • Jyoti Logani, Department of Biotechnology, Ministry of Science and Technology
  • Shekhar Mande, National Center for Cell Science
  • Amit Misra, Central Drug Research Institute
  • Anant Mohan, All India Institute of Medical Science
  • Vinay K. Nandicoori, National Institute of Immunology
  • Amit Kumar Pandey, Translational Health Science and Technology Institute
  • Kanury Rao, Translational Health Science and Technology Institute
  • Alka Sharmar, Department of Biotechnology, Ministry of Science and Technology
  • Pawan Sharma, Department of Biotechnology, Ministry of Science and Technology
  • Manjula Singh, Indian Council of Medical Research
  • Rupak Singla, National Institute of Tuberculosis and Respiratory Diseases
  • Anil Tyagi, Guru Gobind Singh Indraprastha University
  • Jaya S. Tyagi, All India Institute of Medical Sciences
  • Vijaya Lakshmi Valluri, Bhagawan Mahavir Medical Research Centre

International Advisory Panel

  • Peter Andersen, Statens Serum Institut (Denmark)
  • Lijun Bi, Institute of Biophysics, Chinese Academy of Sciences (China)
  • Barry Bloom, Harvard T.H. Chan School of Public Health (USA)
  • Gavin Churchyard, The Aurum Institute (South Africa)
  • Keertan Dheda, University of Cape Town and Groote Schuur Hospital, (South Africa)
  • Lucica Ditiu, Stop TB Partnership (Switzerland)
  • Katrin Eichelberg, National Institute of Allergy and Infectious Diseases, National Institutes of Health (USA)
  • Helen Fletcher, London School of Hygiene and Tropical Medicine (UK)
  • JoAnne Flynn, University of Pittsburgh (USA)
  • Glenda Gray, South African Medical Research Council (South Africa)
  • Sanjay Gurunathan, Sanofi Pasteur (USA)
  • Stefan H.E. Kaufmann, Max Planck Institute for Infection Biology (Germany)
  • Luciana Leite, Instituto Butantan (Brazil)
  • Christian Lienhardt, Global TB Programme, World Health Organization (Switzerland)
  • Souleymane Mboup, Institut de Recherche en Santé, de Surveillance Epidemiologique et de Formations (Senegal)
  • Helen McShane, University of Oxford (UK)
  • Norazmi Mohd Nor, Universiti Sains Malaysia (Malaysia)
  • Ole Olesen, European & Developing Countries Clinical Trials Partnership (Netherlands)
  • Tom Ottenhoff, Leiden University Medical Centre (Netherlands)
  • Johan Vekemans, Initiative for Vaccine Research, World Health Organization (Switzerland)